Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope

Torsten Matthias, Sascha Pfeiffer, Carlo Selmi, M. Eric Gershwin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising serological tool for the detection of anti-tissue transglutaminase as well as antigliadin antibodies.

Original languageEnglish (US)
Pages (from-to)298-301
Number of pages4
JournalClinical Reviews in Allergy and Immunology
Volume38
Issue number2-3
DOIs
StatePublished - Apr 2010

Fingerprint

Celiac Disease
Epitopes
Antigens
Sensitivity and Specificity
Antibodies
Research
transglutaminase 2

Keywords

  • Anti-gliadin antibodies
  • Celiac disease
  • Tissue transglutaminase

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. / Matthias, Torsten; Pfeiffer, Sascha; Selmi, Carlo; Gershwin, M. Eric.

In: Clinical Reviews in Allergy and Immunology, Vol. 38, No. 2-3, 04.2010, p. 298-301.

Research output: Contribution to journalArticle

@article{d3cb5963efca4f51a38312ee7ee0774e,
title = "Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope",
abstract = "The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising serological tool for the detection of anti-tissue transglutaminase as well as antigliadin antibodies.",
keywords = "Anti-gliadin antibodies, Celiac disease, Tissue transglutaminase",
author = "Torsten Matthias and Sascha Pfeiffer and Carlo Selmi and Gershwin, {M. Eric}",
year = "2010",
month = "4",
doi = "10.1007/s12016-009-8160-z",
language = "English (US)",
volume = "38",
pages = "298--301",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "2-3",

}

TY - JOUR

T1 - Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope

AU - Matthias, Torsten

AU - Pfeiffer, Sascha

AU - Selmi, Carlo

AU - Gershwin, M. Eric

PY - 2010/4

Y1 - 2010/4

N2 - The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising serological tool for the detection of anti-tissue transglutaminase as well as antigliadin antibodies.

AB - The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising serological tool for the detection of anti-tissue transglutaminase as well as antigliadin antibodies.

KW - Anti-gliadin antibodies

KW - Celiac disease

KW - Tissue transglutaminase

UR - http://www.scopus.com/inward/record.url?scp=77953321853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953321853&partnerID=8YFLogxK

U2 - 10.1007/s12016-009-8160-z

DO - 10.1007/s12016-009-8160-z

M3 - Article

C2 - 19629760

AN - SCOPUS:77953321853

VL - 38

SP - 298

EP - 301

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 2-3

ER -